Security key
92511W108
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)
CUSIP: 92511W108
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 92,448,158
- Total 13F shares
- 24,695,954
- Share change
- -4,772,092
- Total reported value
- $13,342,110
- Price per share
- $0.53
- Number of holders
- 52
- Value change
- -$2,100,389
- Number of buys
- 23
- Number of sells
- 51
Report period
Q2 2025
Institutions
52
Top holders
10
VRCA full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Verrica Pharmaceuticals Inc. SEC filings
Verrica Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92511W108
Recent filing periods:
Top shareholders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Caligan Partners LP |
13D/G
13F
|
Company |
10%
|
15,856,653
|
$7,769,760 | $0 | 31 Dec 2024 | |
| ARMISTICE CAPITAL, LLC |
13D/G
13F
|
Company |
10%
|
9,235,571
|
$7,480,813 | +$81,611 | 31 Mar 2025 | |
| PERCEPTIVE ADVISORS LLC |
3/4/5
13D/G
|
10%+ Owner |
1.6%
from 13D/G
|
7,099,182
|
$51,398,078 | — | 27 Dec 2023 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
3%
|
2,807,346
|
$1,241,408 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.6%
|
2,361,321
|
$1,043,704 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.3%
|
1,227,554
|
$542,824 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
1,018,486
|
$450,402 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.85%
|
790,163
|
$349,253 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.61%
|
567,048
|
$250,749 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.47%
|
434,748
|
$192,246 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.43%
|
395,651
|
$174,957 | — | 31 Mar 2025 | |
| Sovran Advisors, LLC |
13F
|
Company |
0.42%
|
392,163
|
$192,160 | — | 31 Mar 2025 | |
| BML Capital Management, LLC |
13F
|
Company |
0.19%
|
174,651
|
$77,231 | — | 31 Mar 2025 | |
| Mariner, LLC |
13F
|
Company |
0.18%
|
165,188
|
$73,046 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.15%
|
139,055
|
$61,490 | — | 31 Mar 2025 | |
| Kovitz Investment Group Partners, LLC |
13F
|
Company |
0.11%
|
101,125
|
$44,717 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.11%
|
99,505
|
$44,001 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.1%
|
88,674
|
$39,212 | — | 31 Mar 2025 | |
| Composition Wealth, LLC |
13F
|
Company |
0.09%
|
84,000
|
$37,145 | — | 31 Mar 2025 | |
| SteelPeak Wealth, LLC |
13F
|
Company |
0.08%
|
76,000
|
$33,608 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.08%
|
74,388
|
$32,895 | — | 31 Mar 2025 | |
| BECK MACK & OLIVER LLC |
13F
|
Company |
0.08%
|
70,000
|
$30,954 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
69,423
|
$30,699 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.06%
|
58,711
|
$25,962 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.06%
|
57,100
|
$25,250 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.06%
|
54,122
|
$23,933 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
50,000
|
$22,110 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
44,383
|
$19,626 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
43,613
|
$19,285 | — | 31 Mar 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.04%
|
41,482
|
$18,000 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
34,941
|
$15,436 | — | 31 Mar 2025 | |
| SPC Financial, Inc. |
13F
|
Company |
0.03%
|
30,000
|
$13,266 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.03%
|
29,110
|
$12,873 | — | 31 Mar 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.03%
|
28,730
|
$13,000 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
25,351
|
$11,205 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.02%
|
21,591
|
$9,548 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
20,309
|
$8,981 | — | 31 Mar 2025 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.02%
|
19,804
|
$8,757 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
19,314
|
$8,541 | — | 31 Mar 2025 | |
| Creative Planning |
13F
|
Company |
0.02%
|
19,018
|
$8,410 | — | 31 Mar 2025 | |
| Capital Analysts, LLC |
13F
|
Company |
0.02%
|
16,300
|
$7,000 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.02%
|
15,620
|
$6,907 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.02%
|
15,605
|
$6,901 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
15,242
|
$6,740 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.01%
|
12,200
|
$5,395 | — | 31 Mar 2025 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
|
Company |
0.01%
|
11,873
|
$5,250 | — | 31 Mar 2025 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.01%
|
11,500
|
$5,000 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.01%
|
11,288
|
$4,992 | — | 31 Mar 2025 | |
| Key FInancial Inc |
13F
|
Company |
0.01%
|
9,415
|
$4,163 | — | 31 Mar 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
9,076
|
$4,013 | — | 31 Mar 2025 |
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q2 2025
As of 30 Jun 2025,
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,695,954 shares.
The largest 10 holders included
Caligan Partners LP, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Sovran Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, Mariner, LLC, NORTHERN TRUST CORP, Y-Intercept (Hong Kong) Ltd, and GOLDMAN SACHS GROUP INC.
This page lists
53
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
72
Q2 2025 holders
52
Holder diff
-20
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.